Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Pavel Klvaňa"'
Autor:
Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Drastich, Premysl Falt, Pavel Klvana, Vaclav Leksa, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas, Dana Duricova
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Vedolizumab demonstrated different placental pharmacokinetics than other immunoglobulin G1 antibodies, leading to lower drug levels in cord blood in contrast to maternal blood at the time of delivery. The placental transfer of ustekinumab
Externí odkaz:
https://doaj.org/article/66e3c88cc9384a3790d80746cc08cc2d
Autor:
Barbora Pipek, Dana Ďuricová, Katarína Mitrová, Martin Bortlík, Luděk Bouchner, Jan Březina, Tomáš Douda, Tomáš Drašar, Pavel Drastich, Přemysl Falt, Pavel Klvaňa, Pavel Kohout, Václav Leksa, Aleš Novotný, Pavel Svoboda, Jan Škorpík, Jan Ulbrych, Marek Veinfurt, Blanka Zbořilová, Milan Lukáš
Publikováno v:
Gastroenterologie a hepatologie. 76:46-54
Background: Inflammatory bowel disease (IBD) is mostly diagnosed in young women of fertile age, and a significant number of patients become pregnant while they have the disease. The remission of the illness, which is often achieved by intensive anti
Autor:
Pavel Řeha, Petr Vítek, Pavel Klvaňa, Jiří Platoš, Jan Kuchař, Ivana Mikoviny Kajzrlíková, Josef Chalupa
Publikováno v:
Gastroenterologie a hepatologie. 73:215-219
Publikováno v:
Gastroenterologie a hepatologie. 70:331-334
Autor:
Tomáš Kupka, Pavel Klvaňa, Martin Blaho, Pavel Svoboda, Petr Dítě, Arnošt Martínek, Martin Rydlo, Martina Bojková
Publikováno v:
Vnitrni lekarstvi. 63(1)
Sclerosing cholangitides represent a group of chronic biliary obstructive diseases which include primary sclerosing cholangitis (PSC), IgG4 associated sclerosing cholangitis (IgG4-SC) and secondary sclerosing cholangitis (SSC). The manifestations of
Autor:
Martin, Rydlo, Jana, Dvořáčková, Tomáš, Kupka, Pavel, Klvaňa, Jaroslav, Havelka, Magdalena, Uvírová, Edvard, Geryk, Daniel, Czerný, Tomáš, Jonszta, Martina, Bojková, Vladimír, Hrabovský, Veronika, Jelínková, Arnošt, Martínek, Petr, Dítě
Publikováno v:
Vnitrni lekarstvi. 62(2)
Cholangiocarcinoma (CC) is a rare malignant tumour arising from cholangiocytes, and its prognosis is usually unfavourable, mostly as a result of late diagnosis of the tumour. The current incidence of cholangiocarcinoma in the Czech Republic is 1.4/10
Autor:
Martina, Bojková, Petr, Dítě, Magdalena, Uvírová, Nina, Dvořáčková, Bohuslav, Kianička, Tomáš, Kupka, Pavel, Svoboda, Pavel, Klvaňa, Arnošt, Martínek
Publikováno v:
Vnitrni lekarstvi. 62(2)
One of the diseases involving a potential risk of developing chronic pancreatitis is acute pancreatitis.Of the overall number of 231 individuals followed with a diagnosis of chronic pancreatitis, 56 patients were initially treated for acute pancreati
Autor:
Tomáš, Kupka, Jarmila, Símová, Lubomír, Martínek, Pavel, Svoboda, Pavel, Klvaňa, Martina, Bojková, Magdalena, Uvírová, Lenka, Dovrtělová, Petr, Dítě
Publikováno v:
Vnitrni lekarstvi. 60(7-8)
Crohn's disease is often purely inflammatory, but most patients develop complicated disease with strictures or fistulae. Specific etiopathogenesis of this severe disease is not definitely clear despite research efforts and learning of many pathogenet
Autor:
Martina, Bojková, Pavel, Klvaňa, Pavel, Svoboda, Tomáš, Kupka, Arnošt, Martínek, Marian, Bojko, Petr, Dítě
Publikováno v:
Vnitrni lekarstvi. 60(3)
Treatment of pain is one of the main pillars of treatment of pancreatic diseases. Abdominal pain is a common and often debilitating symptom in patients with chronic pancreatitis and pancreatic cancer. Treatment involves abstinence from tobacco, alcoh
Autor:
Pavel, Svoboda, Petr, Dítě, Pavel, Klvaňa, Tomáš, Kupka, Martina, Bojková, Jana, Žmolíková, Irena, Urbanovská, Magdalena, Uvírová, Petr, Buzrla, Jana, Dvořáčková
Publikováno v:
Vnitrni lekarstvi. 60(5-6)
Gastroesophageal reflux disease is a quite common disorder, and the condition affects some 40 per cent of population in the course of their lifetime. Fortunately, about half of the patients examined due to clear symptoms do not manifest macroscopic d